|
|
Platinum Sponsors
|
|
The Eve Appeal
Maple House
149 Tottenham Court Road
London W1T 7NF
Tel: 020 7380 6900
Fax: 020 7383 7424
Email: office@eveappeal.org.uk
Website: www.eveappeal.org.uk |
The Eve Appeal was set up to save women’s lives by funding groundbreaking research into gynaecological cancers. Its current and most urgent aim is to raise the last £3.4 million by 2010 required to complete a world class research programme at University College London which aims to find techniques that will halve the death rates from ovarian cancer within 10 years. The programme includes the largest ovarian cancer screening trial in the world. |
|
|
|
BD Diagnostics
4025 Stirrup Creek Drive,
Suite 400,
Durham, NC 27703
USA
Tel: +01 919 206 7139
Fax: +01 919 572 6213
Website: www.bd.com |
BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving women’s health throughout the world. With the acquisition of TriPath Imaging, BD expanded its diagnostic offerings to include innovative solutions for cancer screening, diagnosis, prognosis and therapy monitoring for cancers specifically affecting women’s health including cervical, breast and ovarian cancers. BD Diagnostics also provides products for the safe collection and transport of diagnostic specimens and instrumentation for quick, accurate analysis for a broad range of microbiology and infectious disease testing. |
|
Sponsors
|
|
Cytyc and Hologic Together
Cytyc UK,
Link 10, Napier Way,
Crawley,
West Sussex RH10 9RA
Tel: 01293 522080
Website: www.cytyc.com
|
Cytyc and Hologic have combined together under the Hologic name with a shared commitment to enhance women’s health through earlier and better detection, improved diagnosis, less invasive treatments and improved patient outcomes. Together, we hold the number one position in nine technology areas serving women’s health, including breast cancer diagnosis and treatment, cervical cancer screening, treatment of menorrhagia, prenatal testing, and osteoporosis detection. |
|
|
|
Medical Solutions PLC
1 Orchard Place
Nottingham Business Park
NG8 6PX
Tel 0115 973 9013
www.medical-solutions.co.uk |
Medical Solutions are the exclusive distributor in the UK and Ireland for FocalPoint™ GS and SurePath™ (BD-TriPath). Surepath™ is the chosen method of LBC technology in approx 45% of the market and is used exclusively in Wales. All labs using SurePath™ are now fully converted to LBC. FocalPoint™ GS is actively utilized by the HTA in Manchester evaluating the implementation of Automated Imaging within the screening programme.
Additional services available from Medical Solutions include DNA Sequencing, Genotyping, Her2, FISH and diagnostic pathology services.
Our state of the art laboratories are located at Nottingham and are both GLP and CPA accredited. |
|
|
|
ICICI Bank UK PLC
21, Knightsbridge,
London SW1X 7LY
Website: www.icicibank.com |
ICICI Bank UK PLC is a wholly owned subsidiary of ICICI Bank, India's second largest bank, with assets worth about USD 90 billion. With over fifty years of financial experience, ICICI Bank is present across 18 countries and offers a wide variety of banking products and financial services. ICICI Bank’s rapid growth has been accompanied by a long term commitment to enhancing the economic, social as well as human development outcomes. ICICI Group seeks to improve human development outcomes in India by exploring new strategies for change with initiatives in diverse fields such as health, education, infrastructure, bio-technology and agriculture. As an example, the Bank’s Social Initiatives Group has partnered with the University of Southampton, UK & the Society for the Natal Effects of Health in Adults, India to study the effects of micronutrient quality in a maternal diet on foetal survival rates, across 20,000 families from slums in Mumbai, India. |
|
|
|
Polartechnics UK Limited
Office 1,
Units 1-3 Wyvern Estate
New Malden,
Surrey
KT3 4PH
Tel 020-8605 1661
Fax 07902-840388
www.polartechnics.co.uk |
Polartechnics Limited, a leading Australian biotechnology company listed on the Australian Stock Exchange, specialising in cancer detection and screening technologies.
Key products include:
TruScreen, a real time screening device for the detection of cervical cancer, detecting pre-cancer and cancer of the cervix with a high level of accuracy. TruScreen has been CE certified as a stand-alone screening device for the detection of cervical cancer.
MediScan, a digital imaging electronic health record with a highly flexible data set at the point of care. Successfully launched in Australia, UK, Ireland and France.
CerviScreen, a new innovative self-sampling system for the detection of HPV - the cause of almost all cervical cancers. CerviScreen will be launched in May 2008.
Polartechnics is currently building a global distribution network for its portfolio, seeking relationships with established national medical product distributors in relevant target countries.
For further information:
Godfrey Axten, Global Head of TruScreen, 07753 970174
Or Fraser Tully, Polartechnics UK Limited, Tel 020 8605 1661 |
|
|
|
Sanofi Pasteur MSD
Mallards Reach
Bridge Avenue
Maidenhead
Berkshire
SL6 1QP
www.spmsd.co.uk
|
Sanofi Pasteur MSD is the only European company dedicated exclusively to vaccines and was founded in 1994, as a joint venture between Sanofi Pasteur and Merck and Co. Inc.
Sanofi Pasteur MSD develops vaccines, originating from research by both shareholders, and ensures they are available to people across Europe, providing protection from disease for all age groups. |
|
 |
|
Schering-Plough Ltd
Shire Park
Welwyn Garden City
Hertfordshire
AL7 1TW
www.sch-plough.com
|
Schering-Plough is a global science-based healthcare company with leading prescription, consumer and animal health products. The company’s oncology and anti-infectives portfolio encompasses a number of specialist areas, including ovarian cancer, brain tumours and invasive fungal infections.
Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough’s vision is to earn the trust of the physicians, patients and customers served by its workforce of more than 33,500 people around the world. |
|
|
|
Stargate
62-65 Trafalgar Square
London
WC2N 5DY
Tel: 020 7024 9740
Email: info@trapeziacapital.co.uk |
Stargate Capital Investment Group is a London based corporate finance and fund management investment firm focusing on emerging enterprise market segments which are currently underserved by banks and the existing fund management industry. Developed by Stargate, Trapezia is the first venture capital programme in the UK dedicated to investing in women-focused businesses, having closed Trapezia EIS and currently raising the Trapezia II Fund. |
|
 |
|
Syner-Med (Pharmaceutical Products) Ltd,
Beech House
840 Brighton Road,
Purley
CR8 2BH
Tel: 0845 634 2100
Fax: 0845 634 2101
Email: mail@syner-med.com
www.syner-med.com |
Syner-Med is the leading company in the management of iron deficiency anaemia. There is significant under treatment of this debilitating condition in both the antenatal and the post partum setting. Anaemia affects not only maternal quality of life, but causes significant morbidity to both mother and child.
Syner-Med has a breakthrough intravenous iron preparation that may correct iron deficit in a single visit, is well tolerated and thus is suitable for primary or secondary care administration. |
|
 |
|
Women's Health Concern
WHC Helpline 0845 123 2319 (M-T 10-2pm; W-F 10-1pm)
advice@womens-health-concern.org
www.womens-health-concern.org
|
Women’s Health Concern (WHC) was founded in 1972 and provides education
and support to women through unbiased, accurate information from our advice
line, email service, and website (a range of fact sheets on the most common
gynaecological and sexual health conditions can be downloaded directly).
|
|
|
|
